GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 23108794
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs | NA | 0.12 | 1 | 23108794
|
AKR1C1 | 384 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0085 | 23108794
|
ARHGDIA | 678 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
CXCL11 | 10638 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
CYTOR | 28717 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
FCER1A | 3609 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
H2AC15 | 4726 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC15 | 4726 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC15 | 4726 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC15 | 4726 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC15 | 4726 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC4 | 4734 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AC4 | 4734 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2AZ2 | 20664 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
H2BC3 | 4751 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H2BU1 | 20514 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
H3C7 | 4773 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
H4C1 | 4781 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
KRT16 | 6423 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0064 | 23108794
|
OR1D4 | 8185 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
OR1D4 | 8186 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
POTEE | 33895 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
RPSA | 6502 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0053 | 23108794
|
RUNX1-IT1 | 16623 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
SERPINB2 | 8584 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0042 | 23108794
|
SLPI | 11092 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0074 | 23108794
|
SSX8P | 19654 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
TMEM145 | 26912 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|
TPMT | 12014 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
UBQLN4 | 1237 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
USP6 | 12629 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
WFS1 | 12762 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0011 | 23108794
|
WNK1 | 14540 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0032 | 23108794
|
ZRSR2 | 23019 | HTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-16A | NA | FACs for CSC marker followed by Transcriptomics | UP | 0.04 | 0.0021 | 23108794
|